These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7587938)

  • 1. Identification of two regioisomeric monocarboxylic acid metabolites of losoxantrone (DuP 941; Biantrazole) excreted in human urine.
    Richards LE; Sun JH
    Drug Metab Dispos; 1995 May; 23(5):600-2. PubMed ID: 7587938
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection and identification of human urinary metabolites of biantrazole (CI-941).
    Blanz J; Renner U; Schmeer K; Ehninger G; Zeller KP
    Drug Metab Dispos; 1993; 21(5):955-61. PubMed ID: 7902262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination pathways of [14C]losoxantrone in four cancer patients.
    Joshi AS; Pieniaszek HJ; Vokes EE; Vogelzang NJ; Davidson AF; Richards LE; Chai MF; Finizio M; Ratain MJ
    Drug Metab Dispos; 2001 Feb; 29(2):96-9. PubMed ID: 11159796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human urinary mitoxantrone metabolites.
    Chiccarelli FS; Morrison JA; Cosulich DB; Perkinson NA; Ridge DN; Sum FW; Murdock KC; Woodward DL; Arnold ET
    Cancer Res; 1986 Sep; 46(9):4858-61. PubMed ID: 3731132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography.
    Proksch B; Blanz J; Zeller KP; Ehninger G
    J Chromatogr B Biomed Appl; 1994 Aug; 658(2):349-53. PubMed ID: 7820263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatography.
    Graham MA; Newell DR; Calvert AH
    J Chromatogr; 1989 Jun; 491(1):253-61. PubMed ID: 2793977
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereoselective metabolic study of famprofazone.
    Neugebauer M; Khedr A; el-Rabbat N; el-Kommos M; Saleh G
    Biomed Chromatogr; 1997; 11(6):356-61. PubMed ID: 9413615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of cleaning procedures for highly potent drugs. I. Losoxantrone.
    Shea JA; Shamrock WF; Abboud CA; Woodeshick RW; Nguyen LQ; Rubino JT; Segretario J
    Pharm Dev Technol; 1996 Apr; 1(1):69-75. PubMed ID: 9552333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oxidative biotransformation of losoxantrone (CI-941).
    Renner UD; Piperopoulos G; Gebhardt R; Ehninger G; Zeller KP
    Drug Metab Dispos; 2002 Apr; 30(4):464-78. PubMed ID: 11901102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors.
    Diab SG; Baker SD; Joshi A; Burris HA; Cobb PW; Villalona-Calero MA; Eckhardt SG; Weiss GR; Rodriguez GI; Drengler R; Kraynak M; Hammond L; Finizio M; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1999 Feb; 5(2):299-308. PubMed ID: 10037178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
    Huan SD; Natale RB; Stewart DJ; Sartiano GP; Stella PJ; Roberts JD; Symes AL; Finizio M
    Clin Cancer Res; 2000 Apr; 6(4):1333-6. PubMed ID: 10778959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and identification of famprofazone and its metabolite in human urine.
    Shin HS; Park JS; Park PB; Yun SJ
    J Chromatogr B Biomed Appl; 1994 Nov; 661(2):255-61. PubMed ID: 7894665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of new propofol metabolites in human urine using gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry techniques.
    Favetta P; Dufresne C; Désage M; Païssé O; Perdrix JP; Boulieu R; Guitton J
    Rapid Commun Mass Spectrom; 2000; 14(20):1932-6. PubMed ID: 11013422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an HPLC-fluorescence determination method for carboxylic acids related to the tricarboxylic acid cycle as a metabolome tool.
    Kubota K; Fukushima T; Yuji R; Miyano H; Hirayama K; Santa T; Imai K
    Biomed Chromatogr; 2005 Dec; 19(10):788-95. PubMed ID: 15971288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
    Bu HZ; Poglod M; Micetich RG; Khan JK
    J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.
    Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A
    Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the metabolites of gestrinone in human urine by high performance liquid chromatography, liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry.
    Kim Y; Lee Y; Kim M; Yim YH; Lee W
    Rapid Commun Mass Spectrom; 2000; 14(18):1717-26. PubMed ID: 10962496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of the main aliphatic carboxylic acids in wood kraft black liquors by high-performance liquid chromatography-mass spectrometry.
    Käkölä J; Alén R; Pakkanen H; Matilainen R; Lahti K
    J Chromatogr A; 2007 Jan; 1139(2):263-70. PubMed ID: 17126848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential cardiotoxicity with the use of DuP-941: a case report.
    Walsh SM; Walley VM; Chandra L; Huan SD; Veinot JP; Higginson LA
    Can J Cardiol; 1995 May; 11(5):419-22. PubMed ID: 7750038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.